title: Primary ocular recurrence of leukemia following bone marrow transplant.
abstract: A patient with acute lymphoblastic leukemia (ALL) who had undergone an allogeneic bone marrow transplant that included high-dose chemotherapy and total body radiation without eye shielding, sustained an isolated relapse of her disease in the iris. A review of ocular leukemic disease is discussed.
authors.affiliation: Department of Pediatrics, North Shore University Hospital, Cornell University Medical College, Manhasset, New York 11030.
authors.forename: I
authors.initials: I
authors.lastname: Sahdev
authors.forename: M E
authors.initials: ME
authors.lastname: Weinblatt
authors.forename: H
authors.initials: H
authors.lastname: Lester
authors.forename: P T
authors.initials: PT
authors.lastname: Finger
authors.forename: J
authors.initials: J
authors.lastname: Kochen
mesh_terms: D001215:Asparaginase / Q000008:administration & dosage; D016026:Bone Marrow Transplantation; D002675:Child, Preschool; D003131:Combined Modality Therapy; D016371:Cranial Irradiation; D003520:Cyclophosphamide / Q000008:administration & dosage; D003561:Cytarabine / Q000008:administration & dosage; D003630:Daunorubicin / Q000008:administration & dosage; D004317:Doxorubicin / Q000008:administration & dosage; D005047:Etoposide / Q000008:administration & dosage; D017809:Fatal Outcome; D005260:Female; D006801:Humans; D007498:Iris / Q000473:pathology*; D017254:Leukemic Infiltration / Q000175:diagnosis / Q000532:radiotherapy; D015122:Mercaptopurine / Q000008:administration & dosage; D008727:Methotrexate / Q000008:administration & dosage; D011184:Postoperative Period; D054198:Precursor Cell Lymphoblastic Leukemia-Lymphoma / Q000188:drug therapy / Q000473:pathology* / Q000532:radiotherapy / Q000601:surgery; D011241:Prednisone / Q000008:administration & dosage; D016879:Salvage Therapy; D013866:Thioguanine / Q000008:administration & dosage; D014750:Vincristine / Q000008:administration & dosage; D014916:Whole-Body Irradiation
chemical_list: D003561:Cytarabine; D014750:Vincristine; D005047:Etoposide; D004317:Doxorubicin; D003520:Cyclophosphamide; D015122:Mercaptopurine; D001215:Asparaginase; D013866:Thioguanine; D011241:Prednisone; D008727:Methotrexate; D003630:Daunorubicin